Hôpital Haut-Lévêque

Pessac, New Aquitaine 33604

1 studies enrolling now · 4 studies all time

What they study most

Advanced or Metastatic NSCLS With Exon 20 Insertion Mutation, EBV Related PTCL, NOS, EBV-Positive DLBCL, NOS, EBV-Related Hodgkin Lymphoma, EBV-Related Lymphoproliferative Disorder, EBV-Related Non-Hodgkin Lymphoma, EBV-Related PTLD, Epstein-Barr Virus Associated Lymphoma, NASH - Nonalcoholic Steatohepatitis, Patients With Non-Small Cell Lung Cancer

Studies at this site

• Trial of Therapeutic Cancer Vaccine OSE2101 in Patients With Non-Small Cell Lung Cancer and Secondary Resistance to Immune Checkpoint Inhibitor — Recruiting now
• REZILIENT3 (REsearching ZIpaLertinib In Egfr Non-small Cell Lung Cancer Tumors) — Running, not enrolling
• A Phase 3 Study Evaluating Efficacy and Safety of Lanifibranor Followed by an Active Treatment Extension in Adult Patients With (NASH) and Fibrosis Stages F2 and F3 ( NATiV3 ) — Running, not enrolling
• An Open-Label Phase 2 Trial of Nanatinostat Plus Valganciclovir in Patients With EBV+ Relapsed/Refractory Lymphomas — Stopped early